002365 永安药业
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)1.2843.106-0.6157.2286.153
总资产报酬率 ROA (%)1.1162.653-0.5165.9595.008
投入资产回报率 ROIC (%)1.2442.985-0.5916.9755.776

边际利润分析
销售毛利率 (%)17.04919.99225.86932.93522.904
营业利润率 (%)3.1608.6950.58110.4218.411
息税前利润/营业总收入 (%)2.9097.319-0.0879.0348.720
净利润/营业总收入 (%)2.8327.118-2.9219.0757.605

收益指标分析
经营活动净收益/利润总额(%)-54.51256.619120.148114.97991.700
价值变动净收益/利润总额(%)140.99762.250616.8743.42518.299
营业外收支净额/利润总额(%)-1.205-2.9256.6670.430-1.400

偿债能力分析
流动比率 (X)5.0244.8274.7174.1923.633
速动比率 (X)4.6864.4504.4463.6683.136
资产负债率 (%)10.92611.54612.73213.24914.390
带息债务/全部投入资本 (%)2.2232.4892.3621.9471.495
股东权益/带息债务 (%)4,365.5163,882.8294,048.6294,947.5206,465.577
股东权益/负债合计 (%)799.528748.007663.854628.128567.241
利息保障倍数 (X)-13.651-6.4810.123-6.30920.509

营运能力分析
应收账款周转天数 (天)65.13668.54862.61249.58040.933
存货周转天数 (天)48.47843.82554.78154.20933.922